{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T06:00:09Z","timestamp":1785477609987,"version":"3.56.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"General project of Chongqing Natural Science Foundation","award":["CSTB2023NSCQ-MSX0246"],"award-info":[{"award-number":["CSTB2023NSCQ-MSX0246"]}]},{"name":"Science and Health Joint Project of Dazu District Science and Technology Bureau","award":["DZKJ2024JSYJ-KWXM1002"],"award-info":[{"award-number":["DZKJ2024JSYJ-KWXM1002"]}]},{"name":"Research project of the State Administration of Traditional Chinese Medicine on collaborative chronic disease management of traditional Chinese medicine and western medicine","award":["CXZH2024087"],"award-info":[{"award-number":["CXZH2024087"]}]},{"name":"Chongqing Medical Leading Talent Project","award":["YXLJ202514"],"award-info":[{"award-number":["YXLJ202514"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bioenerg Biomembr"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10863-026-10126-w","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T05:30:59Z","timestamp":1785475859000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Par-4\/TERT induced autophagy dysregulation in regulating glycolysis in hyperglycemia combined with hepatocellular carcinoma"],"prefix":"10.1007","volume":"58","author":[{"given":"Jiaying","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangfen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotian","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7001-4836","authenticated-orcid":false,"given":"Qinan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"10126_CR1","doi-asserted-by":"publisher","first-page":"776","DOI":"10.4254\/wjh.v6.i11.776","volume":"6","author":"RE Ashworth","year":"2014","unstructured":"Ashworth RE, Wu J (2014) Mammalian target of rapamycin inhibition in hepatocellular carcinoma. World J Hepatol 6:776\u2013782","journal-title":"World J Hepatol"},{"key":"10126_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41419-020-03292-1","volume":"12","author":"AR Cheratta","year":"2021","unstructured":"Cheratta AR, Thayyullathil F, Pallichankandy S, Subburayan K, Alakkal A, Galadari S (2021) Prostate apoptosis response-4 and tumor suppression: it\u2019s not just about apoptosis anymore. Cell Death Dis 12:47","journal-title":"Cell Death Dis"},{"key":"10126_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13072-023-00489-4","volume":"16","author":"R Dhat","year":"2023","unstructured":"Dhat R, Mongad D, Raji S, Arkat S, Mahapatra NR, Singhal N et al (2023) Epigenetic modifier alpha-ketoglutarate modulates aberrant gene body methylation and hydroxymethylation marks in diabetic heart. Epigenetics Chromatin 16:12","journal-title":"Epigenetics Chromatin"},{"key":"10126_CR4","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/path.6421","volume":"266","author":"R Dong","year":"2025","unstructured":"Dong R, Najjar G, G\u00fcnes C, Lechel A (2025) Aberrant TERT expression: linking chronic inflammation to hepatocellular carcinoma(\u2020). J Pathol 266:130\u2013133","journal-title":"J Pathol"},{"key":"10126_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41392-025-02311-x","volume":"10","author":"H Du","year":"2025","unstructured":"Du H, Xu T, Yu S, Wu S, Zhang J (2025) Mitochondrial metabolism and cancer therapeutic innovation. Signal Transduct Target Ther 10:245","journal-title":"Signal Transduct Target Ther"},{"key":"10126_CR6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","volume":"5","author":"J Fares","year":"2020","unstructured":"Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y (2020) Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct Target Ther 5:28","journal-title":"Signal Transduct Target Ther"},{"key":"10126_CR7","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano A, Foo ASC, Lam HY, Yap KCH, Jacot W, Jones RH et al (2023) PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer 22:138","journal-title":"Mol Cancer"},{"key":"10126_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12964-023-01053-z","volume":"21","author":"M Hashemi","year":"2023","unstructured":"Hashemi M, Nadafzadeh N, Imani MH, Rajabi R, Ziaolhagh S, Bayanzadeh SD et al (2023) Targeting and regulation of autophagy in hepatocellular carcinoma: revisiting the molecular interactions and mechanisms for new therapy approaches. Cell Commun Signal 21:32","journal-title":"Cell Commun Signal"},{"key":"10126_CR10","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.cmet.2022.05.003","volume":"34","author":"DQ Huang","year":"2022","unstructured":"Huang DQ, Singal AG, Kono Y, Tan DJH, El-Serag HB, Loomba R (2022) Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer. Cell Metab 34:969\u2013977e962","journal-title":"Cell Metab"},{"key":"10126_CR9","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/S2468-1253(23)00157-7","volume":"8","author":"DQ Huang","year":"2023","unstructured":"Huang DQ, Noureddin N, Ajmera V, Amangurbanova M, Bettencourt R, Truong E et al (2023) Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis. Lancet Gastroenterol Hepatol 8:829\u2013836","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10126_CR11","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.3390\/cancers16213635","volume":"16","author":"MA Jacome","year":"2024","unstructured":"Jacome MA, Wu Q, Pi\u00f1a Y, Etame AB (2024) Evolution of molecular biomarkers and precision molecular therapeutic strategies in glioblastoma. Cancers (Basel) 16:3635","journal-title":"Cancers (Basel)"},{"key":"10126_CR12","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41467-024-55577-0","volume":"16","author":"T Lan","year":"2025","unstructured":"Lan T, Gao F, Cai Y, Lv Y, Zhu J, Liu H et al (2025) The protein circPETH-147aa regulates metabolic reprogramming in hepatocellular carcinoma cells to remodel immunosuppressive microenvironment. Nat Commun 16:333","journal-title":"Nat Commun"},{"key":"10126_CR13","doi-asserted-by":"publisher","first-page":"102994","DOI":"10.4239\/wjd.v16.i5.102994","volume":"16","author":"XT Lei","year":"2025","unstructured":"Lei XT, Chen XF, Qiu S, Tang JY, Geng S, Yang GY et al (2025) TERT\/FOXO1 signaling promotes islet \u03b2-cell dysfunction in type 2 diabetes mellitus by regulating ATG9A-mediated autophagy. World J Diabetes 16:102994","journal-title":"World J Diabetes"},{"key":"10126_CR17","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.2147\/DMSO.S403893","volume":"16","author":"S Li","year":"2023","unstructured":"Li S, Feng F, Deng Y (2023a) Resveratrol regulates glucose and lipid metabolism in diabetic rats by inhibition of PDK1\/AKT phosphorylation and HIF-1\u03b1 expression. Diabetes Metab Syndr Obes 16:1063\u20131074","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10126_CR18","doi-asserted-by":"publisher","first-page":"1320964","DOI":"10.3389\/fphys.2023.1320964","volume":"14","author":"X Li","year":"2023","unstructured":"Li X, Hu S, Cai Y, Liu X, Luo J, Wu T (2023b) Revving the engine: PKB\/AKT as a key regulator of cellular glucose metabolism. Front Physiol 14:1320964","journal-title":"Front Physiol"},{"key":"10126_CR14","doi-asserted-by":"publisher","first-page":"110149","DOI":"10.1016\/j.abb.2024.110149","volume":"761","author":"D Li","year":"2024","unstructured":"Li D, Xiong Y, Li M, Long L, Zhang Y, Yan H et al (2024a) STC2 knockdown inhibits cell proliferation and glycolysis in hepatocellular carcinoma through promoting autophagy by PI3K\/Akt\/mTOR pathway. Arch Biochem Biophys 761:110149","journal-title":"Arch Biochem Biophys"},{"key":"10126_CR15","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.3748\/wjg.v30.i9.1224","volume":"30","author":"HY Li","year":"2024","unstructured":"Li HY, Zheng LL, Hu N, Wang ZH, Tao CC, Wang YR et al (2024b) Telomerase-related advances in hepatocellular carcinoma: A bibliometric and visual analysis. World J Gastroenterol 30:1224\u20131236","journal-title":"World J Gastroenterol"},{"key":"10126_CR16","doi-asserted-by":"publisher","first-page":"3620","DOI":"10.1038\/s41598-025-87545-z","volume":"15","author":"J Li","year":"2025","unstructured":"Li J, Bai L, Xin Z, Song J, Chen H, Song X et al (2025) TERT-TP53 mutations: a novel biomarker pair for hepatocellular carcinoma recurrence and prognosis. Sci Rep 15:3620","journal-title":"Sci Rep"},{"key":"10126_CR19","doi-asserted-by":"crossref","unstructured":"Liu C, QiNan W, XiaoTian L, MengLiu Y, XiaGuang G, WeiLing L et al (2018) TERT and Akt are involved in the Par-4-dependent apoptosis of islet \u03b2 cells in type 2 diabetes. J Diabetes Res 2018:7653904","DOI":"10.1155\/2018\/7653904"},{"key":"10126_CR20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41419-024-06454-7","volume":"15","author":"M Liu","year":"2024","unstructured":"Liu M, Zhang Y, Jian Y, Gu L, Zhang D, Zhou H et al (2024) The regulations of telomerase reverse transcriptase (TERT) in cancer. Cell Death Dis 15:90","journal-title":"Cell Death Dis"},{"key":"10126_CR22","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1002\/hep4.1891","volume":"6","author":"D Mao","year":"2022","unstructured":"Mao D, Lau ESH, Wu H, Yang A, Fan B, Shi M et al (2022) Risk associations of glycemic burden and obesity with liver cancer-A 10-year analysis of 15,280 patients with type 2 diabetes. Hepatol Commun 6:1350\u20131360","journal-title":"Hepatol Commun"},{"key":"10126_CR24","doi-asserted-by":"publisher","first-page":"115064","DOI":"10.1016\/j.celrep.2024.115064","volume":"43","author":"Y Mao","year":"2024","unstructured":"Mao Y, Xia Z, Xia W, Jiang P (2024) Metabolic reprogramming, sensing, and cancer therapy. Cell Rep 43:115064","journal-title":"Cell Rep"},{"key":"10126_CR23","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/s41423-025-01310-w","volume":"22","author":"H Mao","year":"2025","unstructured":"Mao H, Zhao X, Sun SC (2025) NF-\u03baB in inflammation and cancer. Cell Mol Immunol 22:811\u2013839","journal-title":"Cell Mol Immunol"},{"key":"10126_CR25","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/path.6351","volume":"264","author":"M Mishima","year":"2024","unstructured":"Mishima M, Takai A, Takeda H, Iguchi E, Nakano S, Fujii Y et al (2024) TERT upregulation promotes cell proliferation via degradation of p21 and increases carcinogenic potential. J Pathol 264:318\u2013331","journal-title":"J Pathol"},{"key":"10126_CR26","doi-asserted-by":"publisher","first-page":"1472574","DOI":"10.3389\/fcell.2024.1472574","volume":"12","author":"WH Mohammed","year":"2024","unstructured":"Mohammed WH, Sulaiman GM, Abomughaid MM, Klionsky DJ, Abu-Alghayth MH (2024) The dual role of autophagy in suppressing and promoting hepatocellular carcinoma. Front Cell Dev Biol 12:1472574","journal-title":"Front Cell Dev Biol"},{"key":"10126_CR21","doi-asserted-by":"publisher","first-page":"e0120531","DOI":"10.1371\/journal.pone.0120531","volume":"10","author":"T M\u00fchlenberg","year":"2015","unstructured":"M\u00fchlenberg T, Grunewald S, Treckmann J, Podleska L, Schuler M, Fletcher JA et al (2015) Inhibition of KIT-glycosylation by 2-deoxyglucose abrogates KIT-signaling and combination with ABT-263 synergistically induces apoptosis in gastrointestinal stromal tumor. PLoS ONE 10:e0120531","journal-title":"PLoS ONE"},{"key":"10126_CR27","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.3390\/biomedicines11041091","volume":"11","author":"AI Palamarchuk","year":"2023","unstructured":"Palamarchuk AI, Kovalenko EI, Streltsova MA (2023) Multiple actions of telomerase reverse transcriptase in cell death regulation. Biomedicines 11:1091","journal-title":"Biomedicines"},{"key":"10126_CR28","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s12276-025-01415-2","volume":"57","author":"S Park","year":"2025","unstructured":"Park S, Hall MN (2025) Metabolic reprogramming in hepatocellular carcinoma: mechanisms and therapeutic implications. Exp Mol Med 57:515\u2013523","journal-title":"Exp Mol Med"},{"key":"10126_CR29","doi-asserted-by":"publisher","first-page":"106553","DOI":"10.1016\/j.phrs.2022.106553","volume":"187","author":"MDA Paskeh","year":"2023","unstructured":"Paskeh MDA, Ghadyani F, Hashemi M, Abbaspour A, Zabolian A, Javanshir S et al (2023) Biological impact and therapeutic perspective of targeting PI3K\/Akt signaling in hepatocellular carcinoma: Promises and Challenges. Pharmacol Res 187:106553","journal-title":"Pharmacol Res"},{"issue":"1","key":"10126_CR30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10238-024-01527-5","volume":"25","author":"F Rahdan","year":"2024","unstructured":"Rahdan F, Abedi F, Dianat-Moghadam H, Sani MZ, Taghizadeh M, Alizadeh E (2024) Autophagy-based therapy for hepatocellular carcinoma: from standard treatments to combination therapy, oncolytic virotherapy, and targeted nanomedicines. Clin Exp Med 25(1):13. https:\/\/doi.org\/10.1007\/s10238-024-01527-5","journal-title":"Clin Exp Med"},{"key":"10126_CR31","doi-asserted-by":"publisher","first-page":"e4867","DOI":"10.1002\/pro.4867","volume":"33","author":"KK Raut","year":"2024","unstructured":"Raut KK, Pandey S, Kharel G, Pascal SM (2024) Evidence of direct interaction between cisplatin and the caspase-cleaved prostate apoptosis response-4 tumor suppressor. Protein Sci 33:e4867","journal-title":"Protein Sci"},{"key":"10126_CR32","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE et al (2022) The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 7:851\u2013861","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10126_CR33","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1016\/j.csbj.2025.06.044","volume":"27","author":"D Sarmadhikari","year":"2025","unstructured":"Sarmadhikari D, Asthana S (2025) Structural insights into Beclin 1 interactions with it\u2019s regulators for autophagy modulation. Comput Struct Biotechnol J 27:3005\u20133035","journal-title":"Comput Struct Biotechnol J"},{"key":"10126_CR34","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.bcp.2008.05.023","volume":"76","author":"G Sethi","year":"2008","unstructured":"Sethi G, Ahn KS, Sung B, Kunnumakkara AB, Chaturvedi MM, Aggarwal BB (2008) SH-5, an AKT inhibitor potentiates apoptosis and inhibits invasion through the suppression of anti-apoptotic, proliferative and metastatic gene products regulated by IkappaBalpha kinase activation. Biochem Pharmacol 76:1404\u20131416","journal-title":"Biochem Pharmacol"},{"key":"10126_CR35","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41419-025-07429-y","volume":"16","author":"T Shi","year":"2025","unstructured":"Shi T, Geng Q, Wang Z, Wen C, Xu J, Jiao Y et al (2025) Friends or foes: a new perspective of tumour metabolic transcriptional modification. Cell Death Dis 16:106","journal-title":"Cell Death Dis"},{"key":"10126_CR36","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.3390\/cells13171495","volume":"13","author":"J Sledziona","year":"2024","unstructured":"Sledziona J, Burikhanov R, Araujo N, Jiang J, Hebbar N, Rangnekar VM (2024) The tumor suppressor Par-4 regulates adipogenesis by transcriptional repression of PPAR\u03b3. Cells 13:1495","journal-title":"Cells"},{"key":"10126_CR37","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S2213-8587(24)00318-8","volume":"13","author":"N Stefan","year":"2025","unstructured":"Stefan N, Yki-J\u00e4rvinen H, Neuschwander-Tetri BA (2025) Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment. Lancet Diabetes Endocrinol 13:134\u2013148","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10126_CR38","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s42003-024-06430-z","volume":"7","author":"K Subburayan","year":"2024","unstructured":"Subburayan K, Thayyullathil F, Pallichankandy S, Cheratta AR, Alakkal A, Sultana M et al (2024) Tumor suppressor Par-4 activates autophagy-dependent ferroptosis. Commun Biol 7:732","journal-title":"Commun Biol"},{"key":"10126_CR40","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.3892\/or.2017.5841","volume":"38","author":"J Tan","year":"2017","unstructured":"Tan J, Jiang X, Yin G, He L, Liu J, Long Z et al (2017) Anacardic acid induces cell apoptosis of prostatic cancer through autophagy by ER stress\/DAPK3\/Akt signaling pathway. Oncol Rep 38:1373\u20131382","journal-title":"Oncol Rep"},{"key":"10126_CR39","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S1470-2045(22)00078-X","volume":"23","author":"DJH Tan","year":"2022","unstructured":"Tan DJH, Ng CH, Lin SY, Pan XH, Tay P, Lim WH et al (2022) Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis. Lancet Oncol 23:521\u2013530","journal-title":"Lancet Oncol"},{"key":"10126_CR41","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.3390\/ijms24032652","volume":"24","author":"LY Tian","year":"2023","unstructured":"Tian LY, Smit DJ, J\u00fccker M (2023) The role of PI3K\/AKT\/mTOR signaling in hepatocellular carcinoma metabolism. Int J Mol Sci 24:2652","journal-title":"Int J Mol Sci"},{"key":"10126_CR42","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1080\/14728222.2022.2147062","volume":"26","author":"ML Tornesello","year":"2022","unstructured":"Tornesello ML, Tornesello AL, Starita N, Cerasuolo A, Izzo F, Buonaguro L et al (2022) Telomerase: a good target in hepatocellular carcinoma? An overview of relevant preclinical data. Expert Opin Ther Targets 26:767\u2013780","journal-title":"Expert Opin Ther Targets"},{"key":"10126_CR43","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","volume":"400","author":"A Vogel","year":"2022","unstructured":"Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A (2022) Hepatocellular carcinoma. Lancet 400:1345\u20131362","journal-title":"Lancet"},{"key":"10126_CR44","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1080\/15548627.2024.2406186","volume":"21","author":"Z Xu","year":"2025","unstructured":"Xu Z, Liu R, Ke H, Xu F, Yang P, Zhang W et al (2025) ATP6V1D drives hepatocellular carcinoma stemness and progression via both lysosome acidification-dependent and -independent mechanisms. Autophagy 21:513\u2013529","journal-title":"Autophagy"},{"key":"10126_CR45","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.21037\/jtd-24-1817","volume":"17","author":"Z Yi","year":"2025","unstructured":"Yi Z, Liu J, Shen L, Hu Y (2025) mTOR and autophagy in acute lung injury pathogenesis and therapeutic potential. J Thorac Dis 17:2679\u20132692","journal-title":"J Thorac Dis"},{"key":"10126_CR46","doi-asserted-by":"publisher","first-page":"166995","DOI":"10.1016\/j.bbadis.2023.166995","volume":"1870","author":"C Zhang","year":"2024","unstructured":"Zhang C, Gu L, Xie H, Liu Y, Huang P, Zhang J et al (2024) Glucose transport, transporters and metabolism in diabetic retinopathy. Biochim Biophys Acta Mol Basis Dis 1870:166995","journal-title":"Biochim Biophys Acta Mol Basis Dis"}],"container-title":["Journal of Bioenergetics and Biomembranes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10863-026-10126-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10863-026-10126-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10863-026-10126-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T05:31:00Z","timestamp":1785475860000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10863-026-10126-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["10126"],"URL":"https:\/\/doi.org\/10.1007\/s10863-026-10126-w","relation":{},"ISSN":["0145-479X","1573-6881"],"issn-type":[{"value":"0145-479X","type":"print"},{"value":"1573-6881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"assertion":[{"value":"12 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study and experimental procedures were approved by the Medical Ethics Committee of the Affiliated Dazu\u2019s Hospital of Chongqing Medical University (approval no.2025LLSC115).","order":1,"name":"Ethics","label":"Ethical Statement and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors agreed to publish the study and The authors have no conflicts of interest.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"43"}}